IGI, Inc., a global, fully integrated clinical-stage biotechnology company focused on developing multispecifics™ in oncology, ...

Drill hole 30-1061, located near the western limit of the 2024 MRE model, intersected 172.5 metres averaging 0.18% Cu and ...

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) ...

President Ferdinand Marcos Jr. on Monday extended his deepest sympathies to the families who lost loved ones and those who ...

Research and development expenses for the first quarter of 2025 were $42.9 million versus $20.7 million for the comparable ...

The U.S. Food and Drug Administration (FDA) approved Kamada's application to manufacture CYTOGAM in May 2023. During the year ...

Sequel is a U.S. based specialty pharma company with expertise in developing and commercializing niche drugs. It has ...

"We built an innovative offering that supports GXO's rapid growth and differentiation in a highly competitive market,” said ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (" Hyperscale Data ” or the " Company ”), today ...

RESEARCH TRIANGLE PARK, N.C., May 05, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today reported ...

ONE week before Filipinos cast their votes on May 12, candidates from the administration-backed Alyansa Para sa Bagong ...